Histogen (NASDAQ:HSTO) Stock Price Down 70%

Histogen Inc. (NASDAQ:HSTO)’s stock price dropped 70% during trading on Friday . The stock traded as low as $0.05 and last traded at $0.15. Approximately 955 shares traded hands during trading, a decline of 96% from the average daily volume of 21,550 shares. The stock had previously closed at $0.50.

Histogen Price Performance

The stock has a market capitalization of $640,927.00, a P/E ratio of -0.05 and a beta of 0.92. The firm’s 50 day moving average price is $0.38 and its 200 day moving average price is $0.38.

Hedge Funds Weigh In On Histogen

An institutional investor recently raised its position in Histogen stock. Renaissance Technologies LLC increased its stake in Histogen Inc. (NASDAQ:HSTO) by 78.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,167,067 shares of the company’s stock after buying an additional 514,387 shares during the period. Renaissance Technologies LLC owned 2.34% of Histogen worth $292,000 at the end of the most recent reporting period.

Histogen Company Profile

Histogen Inc, a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases.